Skip to main content

Advertisement

Log in

Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Introduction

The current study aimed to assess whether childhood-onset craniopharyngioma patients suffer from symptoms of apathy, as assessed by patients themselves and their close others. We further analyzed whether apathy scores are related to symptoms of depression.

Methods

Childhood-onset craniopharyngioma patients (n = 35, 16 female, median age = 22) and matched healthy controls (n = 35, 19 female, median age = 21) were asked to complete self-ratings of the Apathy Evaluation Scale, whereas informant-ratings were obtained from their close others. Depression was assessed by self-ratings using the German version of the Center for Epidemiological Studies Depression Scale. As primary outcome measures, self- and informant-rated apathy scores were compared between patients and healthy controls. As secondary outcome measures, differences between self- and informant-rated apathy within the single groups and associations between apathy and depression were analyzed.

Results

Compared to healthy controls, patients displayed significantly higher apathy levels in informant-ratings (medianpatients = 18, mediancontrols = 12, p = .021), but not in self-ratings (medianpatients = 11, mediancontrols =12, p = .68). In patients, there was a significant discrepancy between self- and informant-rated apathy and self-rated apathy was related to symptoms of depression.

Conclusions

This is the first study to show that childhood-onset craniopharyngioma patients may be at high risk for apathy. Noteworthy, apathy levels in the patient group were judged to be high by their close others but not by the patients themselves, indicating that many patients were not fully aware of their impairments. As apathy is associated with numerous adverse outcomes affecting everyday life and vocational opportunities, future investigations are needed to identify specific risk factors for apathy.

Clinical Trial Registration No: NCT00258453.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

CP:

Craniopharyngioma

References

  1. Muller HL, Merchant TE, Puget S, Martinez-Barbera JP (2017) New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol https://doi.org/10.1038/nrendo.2016.217

    Article  PubMed  Google Scholar 

  2. Muller HL (2016) Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 23:81–89. https://doi.org/10.1097/MED.0000000000000214

    Article  CAS  PubMed  Google Scholar 

  3. Ozyurt J, Muller HL, Thiel CM (2015) A systematic review of cognitive performance in patients with childhood craniopharyngioma. J Neurooncol 125:9–21. https://doi.org/10.1007/s11060-015-1885-z

    Article  PubMed  Google Scholar 

  4. Zada G, Kintz N, Pulido M, Amezcua L (2013) Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. PLoS ONE 8:e76562. https://doi.org/10.1371/journal.pone.0076562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA, Pereira AM (2006) Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 154:483–489. https://doi.org/10.1530/eje.1.02114

    Article  CAS  PubMed  Google Scholar 

  6. Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel AM, Muller HL (2015) Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 17:1029–1038. https://doi.org/10.1093/neuonc/nov044

    Article  PubMed  PubMed Central  Google Scholar 

  7. Muller HL (2010) Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol 2010:519607 https://doi.org/10.1155/2010/519607

    Article  PubMed  PubMed Central  Google Scholar 

  8. Laffond C, Dellatolas G, Alapetite C, Puget S, Grill J, Habrand JL, Doz F, Chevignard M (2012) Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj 26:270–281. https://doi.org/10.3109/02699052.2011.648709

    Article  CAS  PubMed  Google Scholar 

  9. Marin RS (1990) Differential diagnosis and classification of apathy. Am J Psychiatry 147:22–30. https://doi.org/10.1176/ajp.147.1.22

    Article  CAS  PubMed  Google Scholar 

  10. Weitzner MA (1998) Neuropsychiatry and pituitary disease: an overview. Psychother Psychosom 67:125–132

    Article  CAS  PubMed  Google Scholar 

  11. Weitzner MA, Kanfer S, Booth-Jones M (2005) Apathy and pituitary disease: it has nothing to do with depression. J Neuropsychiatry Clin Neurosci 17:159–166. https://doi.org/10.1176/jnp.17.2.159

    Article  PubMed  Google Scholar 

  12. Fox ME, King TZ (2016) Pituitary disorders as a predictor of apathy and executive dysfunction in adult survivors of childhood brain tumors. Pediatric Blood Cancer 63:2019–2025. https://doi.org/10.1002/pbc.26144

    Article  PubMed  Google Scholar 

  13. Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243–254. https://doi.org/10.1176/jnp.3.3.243

    Article  CAS  PubMed  Google Scholar 

  14. Starkstein SE, Petracca G, Chemerinski E, Kremer J (2001) Syndromic validity of apathy in Alzheimer’s disease. Am J Psychiatry 158:872–877. https://doi.org/10.1176/appi.ajp.158.6.872

    Article  CAS  PubMed  Google Scholar 

  15. Robert P, Onyike CU, Leentjens AFG, Dujardin K, Aalten P, Starkstein S, Verhey FRJ, Yessavage J, Clement JP, Drapier D, Bayle F, Benoit M, Boyer P, Lorca PM, Thibaut F, Gauthier S, Grossberg G, Vellas B, Byrne J (2009) Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders. Eur Psychiatry 24:98–104. https://doi.org/10.1016/j.eurpsy.2008.09.001

    Article  CAS  PubMed  Google Scholar 

  16. Resnick B, Zimmerman SI, Magaziner J, Adelman A (1998) Use of the apathy evaluation scale as a measure of motivation in elderly people. Rehabilit Nurs 23:141–147. https://doi.org/10.1002/j.2048-7940.1998.tb01766.x

    Article  CAS  Google Scholar 

  17. van Reekum R, Stuss DT, Ostrander L (2005) Apathy: why care? J Neuropsychiatry Clin Neurosci 17:7–19. https://doi.org/10.1176/jnp.17.1.7

    Article  PubMed  Google Scholar 

  18. Marin RS, Firinciogullari S, Biedrzycki RC (1993) The sources of convergence between measures of apathy and depression. J Affect Disord 28:117–124

    Article  CAS  PubMed  Google Scholar 

  19. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I (1998) Apathy is not depression. J Neuropsychiatry Clin Neurosci 10:314–319. https://doi.org/10.1176/jnp.10.3.314

    Article  CAS  PubMed  Google Scholar 

  20. Marin RS, Firinciogullari S, Biedrzycki RC (1994) Group differences in the relationship between apathy and depression. J Nerv Ment Dis 182:235–239

    Article  CAS  PubMed  Google Scholar 

  21. Moretti R, Signori R (2016) Neural correlates for apathy: frontal-prefrontal and parietal cortical- subcortical circuits. Front Aging Neurosci 8:289. https://doi.org/10.3389/fnagi.2016.00289

    Article  PubMed  PubMed Central  Google Scholar 

  22. Le Heron C, Apps MAJ, Husain M (2017) The anatomy of apathy: a neurocognitive framework for amotivated behaviour. Neuropsychologia https://doi.org/10.1016/j.neuropsychologia.2017.07.003

    Article  PubMed  Google Scholar 

  23. Hua C, Shulkin BL, Indelicato DJ, Li Y, Li X, Boop FA, Merchant TE (2015) Postoperative cerebral glucose metabolism in pediatric patients receiving proton therapy for craniopharyngioma. J Neurosurg 16:567–573 https://doi.org/10.3171/2015.4.PEDS159

    Article  Google Scholar 

  24. Ozyurt J, Muller HL, Warmuth-Metz M, Thiel CM (2017) Hypothalamic tumors impact gray and white matter volumes in fronto-limbic brain areas. Cortex 89:98–110. https://doi.org/10.1016/j.cortex.2017.01.017

    Article  PubMed  Google Scholar 

  25. Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the Apathy evaluation scale. Psychiatry Res 38:143–162

    Article  CAS  PubMed  Google Scholar 

  26. Lueken U, Seidl U, Schwarz M, Volker L, Naumann D, Mattes K, Schroder J, Schweiger E (2006) Psychometric properties of a German version of the apathy evaluation scale. Fortschr Neurol Psychiatr 74:714–722. https://doi.org/10.1055/s-2006-932164

    Article  CAS  PubMed  Google Scholar 

  27. Hautzinger M, Bailer M, Hofmeister D, Keller F (2012) Allgemeine depressionsskala. Hogrefe, Göttingen

    Google Scholar 

  28. Radloff LS (1977) The CES-D scale—a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401 doi. https://doi.org/10.1177/014662167700100306

    Article  Google Scholar 

  29. Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325

    Article  CAS  PubMed  Google Scholar 

  30. Schwarz R, Krauss O, Hinz A (2003) Fatigue in the general population. Onkologie 26:140–144 doi:69834

    CAS  PubMed  Google Scholar 

  31. Kuhnt S, Ernst J, Singer S, Ruffer JU, Kortmann RD, Stolzenburg JU, Schwarz R (2009) Fatigue in cancer survivors-prevalence and correlates. Onkologie 32:312–317. https://doi.org/10.1159/000215943

    Article  PubMed  Google Scholar 

  32. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545

    Article  CAS  PubMed  Google Scholar 

  33. Sander C, Hegerl U, Wirkner K, Walter N, Kocalevent RD, Petrowski K, Glaesmer H, Hinz A (2016) Normative values of the Epworth sleepiness scale (ESS), derived from a large German sample. Sleep Breath 20:1337–1345. https://doi.org/10.1007/s11325-016-1363-7

    Article  PubMed  Google Scholar 

  34. Bloch KE, Schoch OD, Zhang JN, Russi EW (1999) German version of the Epworth sleepiness scale. Respiration 66:440–447. https://doi.org/10.1159/000029408

    Article  CAS  PubMed  Google Scholar 

  35. Handwerker G (2007) Narkolepsie. Monatsschr Kinderheilkd 155:624–629

    Article  Google Scholar 

  36. Wolff JE, Daumling E, Dirksen A, Dabrock A, Hartmann M, Jurgens H (1996) Munster Heidelberg abilities scale—a measuring instrument for global comparison of illness sequelae. Klin Padiatr 208:294–298. https://doi.org/10.1055/s-2008-1046486

    Article  CAS  PubMed  Google Scholar 

  37. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  CAS  PubMed  Google Scholar 

  38. Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37:1345–1351

    Article  CAS  PubMed  Google Scholar 

  39. Hoffmann A, Warmth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, Calaminus G, Muller HL (2014) Childhood craniopharyngioma—changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Klin Padiatr 226:161–168. https://doi.org/10.1055/s-0034-1368785

    Article  CAS  PubMed  Google Scholar 

  40. Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kuhl J, Gutjahr P, Sorensen N, Calaminus G (2001) Obesity after childhood craniopharyngioma-German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 213:244–249. https://doi.org/10.1055/s-2001-16855

    Article  CAS  PubMed  Google Scholar 

  41. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A (1991) Body Mass Index variations: centiles from birth to 87 years. Eur J Clin Nutr 45:13–21

    CAS  PubMed  Google Scholar 

  42. Muller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sorensen N, Calaminus G, Study Committee of K (2011) Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 165:17–24. https://doi.org/10.1530/EJE-11-0158

    Article  CAS  PubMed  Google Scholar 

  43. Muller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, Pohl F, Calaminus G, Sorensen N (2012) Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab 97:3935–3943. https://doi.org/10.1210/jc.2012-2069

    Article  CAS  PubMed  Google Scholar 

  44. Radakovic R, Harley C, Abrahams S, Starr JM (2015) A systematic review of the validity and reliability of apathy scales in neurodegenerative conditions. Int Psychogeriatr 27:903–923. https://doi.org/10.1017/S1041610214002221

    Article  PubMed  Google Scholar 

  45. Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E (2004) Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46:220–229

    Article  PubMed  Google Scholar 

  46. Levi RB, Drotar D (1999) Health-related quality of life in childhood cancer: discrepancy in parent-child reports. Int J Cancer Suppl 12:58–64

    Article  CAS  PubMed  Google Scholar 

  47. Heinks K, Boekhoff S, Hoffmann A, Warmuth-Metz M, Eveslage M, Peng J, Calaminus G, Muller HL (2018) Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. Endocrine 59:364–372. https://doi.org/10.1007/s12020-017-1489-9

    Article  CAS  PubMed  Google Scholar 

  48. Canning EH, Canning RD, Boyce WT (1992) Depressive symptoms and adaptive style in children with cancer. J Am Acad Child Adolesc Psychiatry 31:1120–1124. https://doi.org/10.1097/00004583-199211000-00021

    Article  CAS  PubMed  Google Scholar 

  49. Grace J, Malloy P (2001) The frontal systems behavior scale manual. Psychological Assessment Resources, Odessa

    Google Scholar 

  50. Drijgers RL, Verhey FR, Leentjens AF, Kohler S, Aalten P (2011) Neuropsychological correlates of apathy in mild cognitive impairment and Alzheimer’s disease: the role of executive functioning. Int Psychogeriatr 23:1327–1333. https://doi.org/10.1017/S1041610211001037

    Article  PubMed  Google Scholar 

  51. Balazs J, Miklosi M, Kereszteny A, Hoven CW, Carli V, Wasserman C, Apter A, Bobes J, Brunner R, Cosman D, Cotter P, Haring C, Iosue M, Kaess M, Kahn JP, Keeley H, Marusic D, Postuvan V, Resch F, Saiz PA, Sisask M, Snir A, Tubiana A, Varnik A, Sarchiapone M, Wasserman D (2013) Adolescent subthreshold-depression and anxiety: psychopathology, functional impairment and increased suicide risk. J Child Psychol Psychiatry 54:670–677. https://doi.org/10.1111/jcpp.12016

    Article  PubMed  Google Scholar 

  52. Zenker S, Haverkamp F, Klingmuller D (2002) Growth hormone deficiency in pituitary disease: relationship to depression, apathy and somatic complaints. Eur J Endocrinol 147:165–171

    Article  CAS  PubMed  Google Scholar 

  53. Mortby ME, Maercker A, Forstmeier S (2012) Apathy: a separate syndrome from depression in dementia? A critical review. Aging Clin Exp Res 24:305–316. https://doi.org/10.3275/8105

    Article  PubMed  Google Scholar 

  54. Duffy J (2000) Apathy in neurologic disorders. Current Psychiatry Rep 2:434–439. https://doi.org/10.1007/s11920-000-0029-z

    Article  CAS  Google Scholar 

  55. Thobois S, Prange S, Sgambato-Faure V, Tremblay L, Broussolle E (2017) Imaging the etiology of apathy, anxiety, and depression in Parkinson’s disease: implication for treatment. Curr Neurol Neurosci Rep 17:76. https://doi.org/10.1007/s11910-017-0788-0

    Article  PubMed  Google Scholar 

  56. Skorvanek M, Gdovinova Z, Rosenberger J, Saeedian RG, Nagyova I, Groothoff JW, van Dijk JP (2015) The associations between fatigue, apathy, and depression in Parkinson’s disease. Acta Neurol Scand 131:80–87. https://doi.org/10.1111/ane.12282

    Article  CAS  PubMed  Google Scholar 

  57. Carroll C, Watson P, Spoudeas HA, Hawkins MM, Walker DA, Clare IC, Holland AJ, Ring HA (2013) Prevalence, associations, and predictors of apathy in adult survivors of infantile (< 5 years of age) posterior fossa brain tumors. Neuro Oncol 15:497–505. https://doi.org/10.1093/neuonc/nos320

    Article  PubMed  PubMed Central  Google Scholar 

  58. Ailion AS, Hortman K, King TZ (2017) Childhood brain tumors: a systematic review of the structural neuroimaging literature. Neuropsychol Rev 27:220–244. https://doi.org/10.1007/s11065-017-9352-6

    Article  PubMed  Google Scholar 

  59. Zhang Y, Zou P, Mulhern RK, Butler RW, Laningham FH, Ogg RJ (2008) Brain structural abnormalities in survivors of pediatric posterior fossa brain tumors: a voxel-based morphometry study using free-form deformation. Neuroimage 42:218–229. https://doi.org/10.1016/j.neuroimage.2008.04.181

    Article  PubMed  Google Scholar 

  60. Muller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sorensen N, Calaminus G (2011) Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 165:17–24. https://doi.org/10.1530/EJE-11-0158

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge Saskia Sauer for helping in the collection and analysis of data.

Disclosure

The authors have no financial relationships relevant to this article to disclose.

Funding

This work was funded by a Grant (DKS2014.13) of the German Childhood Cancer Foundation, Bonn, Germany and a Grant (Forschungspool) of the European Medical School, Oldenburg, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aylin Mehren.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mehren, A., Özyurt, J., zu Klampen, P. et al. Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma. J Neurooncol 140, 27–35 (2018). https://doi.org/10.1007/s11060-018-2936-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-018-2936-z

Keywords

Navigation